title: Neonatal purpura fulminans manifestation in early-onset group B Streptococcal infection.
abstract: METHODS
  Male, 0 FINAL DIAGNOSIS: Purpura fulminans Symptoms: Fever • letargy
  
  
  METHODS
  - Clinical Procedure: - Specialty: Pediatrics and Neonatology.
  
  
  OBJECTIVE
  Rare disease.
  
  
  BACKGROUND
  Neonatal purpura fulminans (PF) is a rare but frequently fatal disorder associated with high morbidity and mortality. It may be congenital, as a result of protein C and S deficiency, or acquired due to severe infection. Gram-negative organisms and Staphylococcus species are the most common causes of the acute infectious type, and a few cases of causative neonatal group B Streptococcus (GBS) disease have been reported worldwide.
  
  
  METHODS
  We present a full-term male neonate with purpura fulminans secondary to early-onset group B streptococcal (GBS) infection. The mother brought the infant to the emergency department at the age of 43 hours of life, with fever (39.5°C) and lethargy. Neonatal sepsis was suspected, and he was immediately started on intravenous ampicillin and gentamicin. The initial workup revealed disseminated intravascular coagulopathy, and both blood and CSF cultures grew GBS. He had normal levels of protein C and protein S for his age. The infant died 48 hours after admission due to multiorgan system failure despite aggressive neonatal intensive care support.
  
  
  CONCLUSIONS
  Neonatal PF secondary to early-onset GBS infection is a fatal condition that should not be missed. Screening pregnant women for GBS colonization and use of protocols for preventing perinatal GBS infection is considered the most important preventive measure of this fatal condition, especially among Saudi women, who have a relatively high rate of GBS infection.
authors: King Fahad Medical City, Riyadh, Saudi Arabia.
authors: May
authors: M
authors: Albarrak
authors: Abdulrahman
authors: A
authors: Al-Matary
keywords: GBS; early onset sepsis; neonatal; purpura fulminans
references: Arch Dis Child. 2011 Nov;96(11):1066-71
references: 21233082
references: Saudi Med J. 2002 Jan;23(1):56-61
references: 11938365
references: J Infect Dis. 1990 Sep;162(3):672-7
references: 2201741
references: Burns. 1996 Feb;22(1):53-6
references: 8719318
references: Ital J Pediatr. 2009 Apr 30;35(1):10
references: 19490602
references: Am J Dis Child. 1984 Oct;138(10):915-6
references: 6383017
references: Cutis. 1988 May;41(5):361-3
references: 3286135
references: MMWR Recomm Rep. 1996 May 31;45(RR-7):1-24
references: 8637497
references: J Perinatol. 2009 Jan;29(1):20-5
references: 18704032
references: Pediatr Hematol Oncol. 2010 Nov;27(8):620-5
references: 20795772
references: Obstet Gynecol. 1991 Apr;77(4):604-10
references: 2002986
references: J Perinatol. 1991 Jun;11(2):144-6
references: 1890473
references: J Infect Dis. 1982 Jun;145(6):794-9
references: 7045248
references: Arch Gynecol Obstet. 2011 Sep;284(3):677-9
references: 21079981
references: JAMA. 2008 May 7;299(17):2056-65
references: 18460666
references: J Pediatr. 1973 Dec;83(6):919-25
references: 4585831
references: Semin Fetal Neonatal Med. 2011 Dec;16(6):318-22
references: 21839696
references: Clin Pediatr (Phila). 2009 May;48(4):369-75
references: 18832528